NGVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ingevity Corp (NGVT) is not a strong buy for a beginner, long-term investor at this time. The technical indicators show a bearish trend, financial performance is weak with significant YoY declines in revenue and net income, and there are no recent positive catalysts or strong trading signals. While analysts have slightly raised price targets, they remain cautious, and there is no compelling evidence to suggest immediate upside potential.
The MACD is negative and expanding (-0.882), indicating bearish momentum. RSI is neutral at 22.961, and moving averages are converging, showing no clear trend. The stock is trading near support levels (S1: 66.404), but there is no strong indication of a reversal.
Analysts have raised price targets slightly, with BMO Capital increasing it to $70 and noting potential benefits from portfolio restructuring and debt reduction plans.
No recent news or significant trading trends from insiders or hedge funds. The stock has a low implied volatility rank (5.8), indicating limited potential for large price movements.
In Q4 2025, revenue dropped by -14.63% YoY to $255.1M, net income fell by -609.64% YoY to -$84.6M, and EPS declined by -615.22% YoY to -2.37. However, gross margin improved slightly to 34.42%, up 0.94% YoY.
Analysts are mixed. Wells Fargo raised the price target to $65 but remains cautious with an Equal Weight rating due to business uncertainties. BMO Capital raised the target to $70 with an Outperform rating, citing potential benefits from restructuring and buybacks.
